Ben Palleiko

Benjamin L.
Palleiko was the founder of Cielo Therapeutics, Inc., founded in 2012, where the titles held included President, Secretary, Treasurer & Director from 2012 to 2016.
Current jobs include Chief Executive Officer at KalVista Pharmaceuticals, Inc. since 2016, and Chief Executive Officer & Director at KalVista Pharmaceuticals Ltd. since 2016.
Former jobs include Director-Life Sciences Investment Banking at Truist Securities, Inc. from 2003 to 2006; Managing Director at H.
C.
Wainwright & Co. LLC; Chief Financial Officer & SVP at Gene Logic, Inc.; Chief Financial Officer at Penwest Pharmaceuticals Co. from 2006 to 2009; Chief Financial Officer at Nostrum Pharmaceuticals LLC from 2012 to 2013; Vice President-Investment Banking at Robertson Stephens, Inc. from 2000 to 2002; Chief Financial Officer & Senior Vice President at Ore Pharmaceuticals, Inc. from 2009 to 2013; Chief Financial Officer & Senior Vice President at Ore Holdings, Inc. from 2009 to 2010; and Investment banker at SunTrust Bank (Richmond Branch).
Education includes graduate and MBAistration degrees from The University of Chicago, and an undergraduate degree from Tufts University conferred in 1987.